摘要
目的探讨T2DM患者血糖控制情况及不同抗糖尿病治疗方案对HbA1c达标的影响。方法横断面调查2008～2009年300例T2DM患者的HbA1c达标情况及其与抗糖尿病治疗方案的关系。结果 (1)T2DM患者HbA1c<6.5%和7.0%达标率分别为38.3%和51.7%;(2)不同治疗方案组中,胰岛素联合口服药物组HbA1c最高(P<0.05);(3)口服药物组中,3种及以上药物组HbA1c最高(P<0.05)。结论低胰岛素使用率是T2DM患者血糖控制不良因素之一,启动胰岛素治疗有望改善血糖控制状态。
Objective To investigate the status of blood glucose control in type 2 diabetic patients and the influence of different treatments on their target level of HbA1c.Methods In this cross section investigation,the HbA1c and personal anti-diabetic regimens in 300 type 2 diabetic patients from 2008 to 2009 were recorded and the relationship between the target level of HbA1c and different treatments was analyzed.Results（1） Of the 300 patients,the patients with HbA1c 〈6.5% ＆ 〈7% was 38.3% ＆ 51.7% respectively.（2） Of the groups with different treatments,the HbA1c was the highest in the group treated by insulin combined with oral anti-diabetic drugs（P〈0.05）.（3） Of the oral anti-diabetic drug groups,the HbA1c was the highest in the group treated with 3 and more drugs（P〈0.05）.Conclusion The conservative anti-diabetic regimens is an important factor for the poor blood glucose control in type 2 diabetic patients.Application of insulin early is helpful in improving the blood glucose control.
出处
《中国糖尿病杂志》
CAS
CSCD
北大核心
2012年第7期541-542,共2页
Chinese Journal of Diabetes
关键词
糖尿病
2型
HBA1C
糖基化
胰岛素
Diabetes mellitus, type 2
Hemoglobin A1 e （HbA1 c）
Glycosylate
Insulin
